20 million doses of COVID-19 vaccines may arrive in 2nd quarter of 2021 – Galvez | Inquirer News

20 million doses of COVID-19 vaccines may arrive in 2nd quarter of 2021 – Galvez

By: - Reporter / @KAguilarINQ
/ 12:09 AM March 09, 2021

MANILA, Philippines — The Philippines may get more than 20 million doses of COVID-19 vaccines in the second quarter of 2021 — that is April, May, or June, Secretary Carlito Galvez Jr., vaccine czar and National Task Force against COVID-19 chief implementer, said Monday in a pre-recorded briefing with President Rodrigo Duterte.

Although he did not detail the number of doses for each brand, Galvez said these 20 million doses would come from Sinovac BioTech, the World Health Organization-led COVAX facility, Novovax, and AstraZeneca.


The 2.6 million doses of AstraZeneca ordered by the private sector might arrive in May or June, Galvez said.

The Philippine government and the private sector signed an agreement to buy those doses with AstraZeneca in November 2020.


By the second quarter of this year, the government is eyeing to vaccinate economic frontliners.


For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Carlito Galvez Jr., coronavirus Philippines, COVID-19, COVID-19 Vaccines, vaccination rollout
For feedback, complaints, or inquiries, contact us.

© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.